Zobrazeno 1 - 8
of 8
pro vyhledávání: '"K R, Irvine"'
Autor:
Richard Terrill, David L. Bartlett, Michael Gnant, K. R. Irvine, L. A. Noll, Markus Puhlmann, H R Alexander
Publikováno v:
Scopus-Elsevier
Background: Several approaches to gene therapy for cancer have yielded promising results in rodent models. The translation of these results to the clinical realm has been delayed by the lack of tumor models in large animals. We investigated the patte
Autor:
K R, Irvine, M R, Parkhurst, E P, Shulman, J P, Tupesis, M, Custer, C E, Touloukian, P F, Robbins, A G, Yafal, P, Greenhalgh, R P, Sutmuller, R, Offringa, S A, Rosenberg, N P, Restifo
Publikováno v:
Cancer research. 59(11)
To study the induction of anti-"self" CD8+ T-cell reactivity against the tumor antigen gp100, we used a mouse transgenic for a chimeric HLA-A*0201/H-2 Kb molecule (A2/Kb). We immunized the mice with a recombinant vaccinia virus encoding a form of gp1
Publikováno v:
Molecular Approaches to Tumor Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95a842f3ddc36f3e16b5a73dc93b25b0
https://doi.org/10.1142/9789812817259_0011
https://doi.org/10.1142/9789812817259_0011
Autor:
S, Gurunathan, K R, Irvine, C Y, Wu, J I, Cohen, E, Thomas, C, Prussin, N P, Restifo, R A, Seder
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 161(9)
CD40/CD40 ligand interactions have a central role in the induction of both humoral and cellular immunity. In this study, we examined whether a plasmid expressing CD40 ligand/trimer (CD40LT) could enhance immune responses in vivo. BALB/c mice were inj
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 154(9)
P815A is a naturally occurring tumor rejection Ag of the methylcholanthrene-induced murine mastocytoma P815. The gene encoding the Ag P815A, designated P1A, is identical to that encoded in the normal genome of the DBA/2 mouse. A recombinant vaccinia
Autor:
N P, Restifo, I, Bacík, K R, Irvine, J W, Yewdell, B J, McCabe, R W, Anderson, L C, Eisenlohr, S A, Rosenberg, J R, Bennink
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 154(9)
CD8+ T lymphocytes (TCD8+) play an important role in cellular immune responses. TCD8+ recognize MHC class I molecules complexed to peptides of 8 to 10 residues derived largely from cytosolic proteins. Proteins are generally thought to be fragmented i
Autor:
B J, McCabe, K R, Irvine, M I, Nishimura, J C, Yang, P J, Spiess, E P, Shulman, S A, Rosenberg, N P, Restifo
Publikováno v:
Cancer research. 55(8)
Anticancer vaccine strategies can now target intracellular antigens that are involved in the process of malignant transformation, such as oncogene products or mutated tumor suppressor genes. Fragments of these antigens, generally 8-10 amino acids in
Publikováno v:
Folia biologica. 40(1-2)
Activated CD8+ T cells (TCD8+) can directly recognize malignant cells because processed fragments of tumour associated antigens (TAA), 8-10 amino acids in length and complexed with MHC class I molecules, are displayed on tumour cell surfaces. Tumour